2015/2 GaBI Journal Table of Contents

Contents

Editor’s Letter

What to look forward to in GaBI Journal, 2015, Issue 2

Commentary

Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines

Original Research

Product naming, pricing, and market uptake of biosimilars

Differences in pharmacokinetic behaviour of branded enoxaparin and a US generic version in a non-human primate model

Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance

Perspective

Norway, biosimilars in different funding systems. What works?

Regulatory

Korean regulations for biosimilars

Update on US state legislation on biosimilars substitution

Sponsored Article

Sourcing innovator products in the age of biosimilar research

World News

Online biosimilars resource for patients across Latin America

Source URL: https://gabi-journal.net/20152-gabi-journal-table-of-contents.html